XML 50 R39.htm IDEA: XBRL DOCUMENT

Discontinued Operations Sale of VitaMedica (Tables)

9 Months Ended

Mar. 31, 2025

	Three Months Ended		Nine Months Ended
	March 31, 2024		March 31, 2024
Discontinued Operations
Revenue	$	2,673,744	$	6,708,021
Cost of sales	$	587,142	$	1,480,486
Sales, general and administrative expenses	$	1,888,490	$	4,694,350
Depreciation and amortization	$	115,896	$	353,646
Income (loss) from discontinued operations	$	81,978	$	239,908
Accounts receivable net of allowance for doubtful accounts	$	444,730	$	444,730
Fixed assets, net of accumulated depreciation	$	54,791	$	54,791
Total assets	$	4,901,950	$	4,901,950
Total liabilities	$	403,460	$	403,460